Download presentation
1
ASPHYXIA NEONATORUM/HIE
DR BINOD KUMAR SINGH Associate Professor, NMCH, Patna CIAP Executive Board Member 2015 NNF State President-2014 IAP State Secretary ,Bihar NNF State Secretary , Bihar Chief Consultant:- Shiv Shishu Hospital K P C Colony ,Hanuman Nagar, Patna - web site :-
2
ASPHYXIA NEONATORUM D Defined as impaired respiratory gas exchange accompanied by the development of acidosis
4
Definition of perinatal asphyxia
WHO : A failure to initiate and sustain breathing at birth. NNF : Moderate asphyxia Slow gasping breathing or an apgar score of 4-6 at 1 minute of age Severe asphyxia No breathing or an apgar score of 0-3 at 1 minute of age
5
HOW DOES ASPHYXIA OCCUR?
Interruption of umbilical cord blood flow, eg: cord compression during labour Failure of exchange across the placenta, eg: abruption Inadequate perfusion of maternal side of placenta, eg: maternal hypotension Compromised fetus who cannot tolerate transient intermittent hypoxia of normal labour Failure to inflate lungs
6
CHARACTERSITICS OF PERINATAL ASPHYXIA
Profound metabolic acidosis (pH<7.00) Persistence of an Apgar score of 0 to 3 beyond 5 minutes Clinical neurologic sequelae in the immediate neonatal period Evidence of of multiorgan system dysfunction in the immediate neonatal period - derived from the 1992 joint statement of the AAOP and ACOG and the 1999 International Cerebral Palsy Task Force
7
TO ASSESS THE SEVERITY OF ASPHYXIA - Apgar Scores
Signs Colour Blue/pale Blue peripheries Pink Heart rate 0 <100 >100 Respiration 0 Weak, gasping Regular Suction response 0 Slight Cries Tone Fair Active A -Appearance P- Pulse G- Grimace A-Activity R-Respiration
8
Quiz: At birth, a newborn infant is noted to have the following findings: heart rate – 70/min, respiratory effort – poor and irregular, limp, no reflex irritability, blue all over the body. The Apgar score of the baby at this point is? HR 1, RR 1, Tone 1, reflex 0, color 0 APGAR=3
9
PREDISPOSING FACTORS Maternal Causes
Medical conditions eg Pulmonary hypertension Chronic Hypertension Antenatal conditions eg Abnormal uterine contraction Antepartum haemorrhage Prolapsed cord Malpositions etc
10
PREDISPOSING FACTORS Fetal Causes Multiple pregnancies
Big baby with CPD Fetal anomalies - Congenital abnormalities of the lung
11
PATHOPHYSIOLOGY Fetal adaptation to oxygen lack 1. Preferential flow to heart, brain and adrenals aerobic anaerobic metabolism glucose pyruvic acid lactic acid Acidosis Acidosis failure of autoregulation impaired perfusion increasing acidosis Death unless resuscitated
12
PATHOPHYSIOLOGY 2. Primary and Secondary apnoea
Occur as an attempt to minimize metabolic work 3.Fetal response to asphyxia Respiratory metabolic acidosis 4. EEG changes Loss of faster rhythm iso-electric rhythms Prolonged voltage suppression with burst of spike waves indicating risk of significant brain damage
13
CLINICAL FEATURES Apnoea, bradycardia
Altered respiratory pattern - grunting, gasping Cyanosis Pallor-shock Hypotonia Unresponsiveness
14
ORGANS INVOLVED IN ASPHYXIA (1)
Asphyxia results in alteration in blood flow to various organs, hence multiple organ injury Kidney abnormalities occur in 50% of asphyxiated infants. CNS abnormalities in 30% & CVS & pulmonary abnormalities in 25% Renal abnormalities - Oliguria, elevated β2 microglobulin, azotaemina, elevated serum creatinine, acute tubular necrosis
15
ORGANS INVOLVED IN ASPHYXIA (2)
CNS abnormalities - HIE, PV-IVH CVS abnormalities - Ventricular failure (R > L) Tricuspid regurgitation Hypotension Pulmonary abnormalities –Decreased Pulmonary reserve, pulmonary haemorrhage GIT abnormalities - bleeding GIT, NEC Bone marrow abnormalities - Thrombocytopenia etc
16
PATHOLOGY OF BRAIN DAMAGE
Acidosis alteration in cell membrane permeability fluid shift cerebral edema Anoxia chromatolytic changes in neuron neuron necrosis and neuroglia reactions Neuron necrosis may be focal, multifocal or diffuse over the cerebral cortex, brainstem, thalamus, basal ganglia etc
18
Potential pathways for brain injury after hypoxia-ischemia.
Pathophysiology Potential pathways for brain injury after hypoxia-ischemia. Perlman J M Pediatrics 2006;117:S28-S33 ©2006 by American Academy of Pediatrics
19
PATHOLOGY OF BRAIN DAMAGE
Extent of damage depends on: duration of asphyxia severity of asphyxia gestational age alteration in cerebral blood flow changes in glucose/glycogen metabolism in vulnerable areas of brain.
20
Penumbra Accepted definition for penumbra describes the area as "ischemic tissue potentially destined for infarction but it isn't irreversibly injured and the target of any acute therapies." The original definition of the penumbra referred to areas of the brain that were damaged but not yet dead, and offered promise to rescue the brain tissue with the appropriate therapies
22
Pathology Severity and distribution is dependent on several factors
Certain vulnerable areas - cerebral cortex , hippocampus , basal ganglia, thalamus, brain stem, subcortical and periventricular white matter In full term infants gray matter structures affected and in premature infants white matter Four basic and clinically important lesions - Neuronal necrosis, status marmoratus, para-sagittal cerebral injury, periventricular leucomalacia
23
In hypoxic-ischaemic encephalopathy, as the
cerebral edema develops, the brain function is affected in descending order.
24
PATHOCLINICAL CORRELATION
Full term infant Pathology Clinical Signs Parasagittal cortical and Spastic quadriplegia subcortical neurosis especially arms Intellectual deficits Cerebellum Ataxia Brainstem Bulbar palsy
25
PATHOCLINICAL CORRELATION
Preterm infant Pathology Clinical Signs Periventricular leukomalacia Spastic diplegia Status marmoratus of Basal ganglia choreoathetosis,Dystonia Thalamus Mental retardation Cerebral Cortex Mental retardation
26
SEVERITY OF HIE - SARNAT & SARNAT STAGE
Stage I Stage II Stage III Consciousness Hyperalert Lethargic Stuporose Muscle Tone NAD Mild Hypotonia Flaccid Reflexes active Reflexes active intermittent decerebration Primitive Reflexes Present Incomplete Absent sucking weak suck weak or -ve suck -ve Autonomic Function Sympathetic Parasympathetic Both depressed depressed depressed Seizures None Common None EEG Normal Seizure, Isopotential background burst mildly abnormal suppression
27
Mild HIE Muscle tone may be increased slightly
Deep tendon reflexes may be brisk during the first few days. Transient behavioral abnormalities, such as poor feeding, irritability, or excessive crying or sleepiness, may be observed. By 3-4 days of life, the CNS examination findings become normal.
28
Moderate HIE Lethargic, significant hypotonia
Diminished deep tendon reflexes. Grasp, Moro, and sucking reflexes may be sluggish or absent. Occasional periods of apnea. Seizures may occur within the 1st 24 hours of life. Full recovery within 1-2 weeks is possible and is associated with a better long-term outcome.
29
Severe HIE Stupor or coma is typical.
may not respond to any physical stimulus. Breathing may be irregular, and the infant often requires ventilatory support. Generalized hypotonia and depressed deep tendon reflexes are common. Neonatal reflexes (e.g., sucking, swallowing, grasping, Moro) are absent. Disturbances of ocular motion, such as a skewed deviation of the eyes, nystagmus, bobbing, and loss of "doll's eye" (i.e., conjugate) movements may be revealed by cranial nerve examination. Pupils may be dilated, fixed, or poorly reactive to light.
30
Preventing asphyxia Perinatal assessment Perinatal management
Regular antenatal check ups High risk approach Anticipation of complications during labour Timely intervention ( eg. LSCS) Perinatal management Timely referral Management of maternal complications Prevention,
31
PREVENTION Recognition of at risk pregnancies Antenatal monitoring
fetal movements, fetal growth CTG for change in baseline, loss of variability, decelerations fetal scalp pH < immediate delivery repeat in 1 hour normal Co-ordinated care at delivery by paediatrician
32
MANAGEMENT-Investigations
Hx - of pregnancy and resuscitation O/E to exclude other abnormality Metabolic tests - sugar, Ca/P04/Mg, cord BG, ABG, metabolic screen CSF - to exclude infection; assay brain specific creatine kinase EEG - to help with seizure Dx and prognosis Tech. scan - for abnormal uptake in damaged area
33
MANAGEMENT U/S - to exclude PV-IVH
CT scan - to exclude IVH/trauma, demonstrate severity of edema and for prognosis MRI scan Supportive care Monitor B/p, To, blood sugar, correct acidosis and electrolyte inbalance Care of renal failure - low fluid, dialysis Care of cardiac failure - Dopamine, restrict fluid Management of inappropriate ADH secretion - prevent overhydration
34
MANAGEMENT-1 BASIC CARE :Should be a daily routine in the management of all these babies - 1. Strict asepsis. 2. Ensure neutral thermal environment. 3. Monitor vital parameters – HR,RR,BP,and Pulse Oximetry. 4. Urine output. 5. Daily weight. 6. Nutrition.
35
1. Management of shock 1.Hypovolumic shock needs replacement with fluids, plasma, or blood. 2.Cardiogenic shock warrants use of pressors like dopamine and / or dobutamine. In case of refractory shock inspite of use of pressors of 20 microgram/kg/mt steroids may be tried. 3.Septic shock should be suspected based on intrapartum risk factors for sepsis, core axillary mismatch and results of sepsis screen.
36
2-MANAGEMENT of Cerebral Oedema
Minimise cerebral edema Ventilation - to prevent apnoea and maintain PC02 of mmHg Ensure adequate oxygenation Restrict fluid intake Mannitol ?/frusemide - if urine output is established
37
3-Manangement of seizures
Not all seizures require treatment. Only if seizures are more than 3 in a hour or lasting for 3 mts or more they warrant anticonvulant. Phenobarbitone,Phenytoin,initially by loading dose followed by maintenance dose are the first line drugs. In refractory seizures use of drip of midazolam or lorazepam may be required. sodium valproate or Leviterecetam is occasionally used. Use of newer anticonvulants like lamotrigene,clobazam,gabapentin etc is not used well known in neonates.
38
4-MANAGEMENT OF KIDNEY FAILURE
1.Urine output is by itself not a reliable marker renal parameters need to be monitored. 2.Fluid restriction is required once renal failure sets in. A careful evaluation of electrolytes would direct the fluid management. 3.Daily monitoring of urine output, urine specific gravity, and body weight are adjuvant to basic care. 4.Rarely peritoneal dialysis is required in case of persistent oliguria
39
5-Management of metabolic derangement
1.Hypoglycemia needs to be corrected by 10 % D.Only if it is symptomatic it warrants a bolus otherwise in asymptomatic cases maintenance infusion is all that is required. 2.Only symptomatic hypocalcemia needs correction.Evaluate for hypomagnesemia in case of persistent hypocalcemia. 3.Hyponatremia should be anticipated and prevented by restricted fluid administration.
40
Newer modalities Hypothermia
Antagonists of excitotoxic neurotransmitter receptors - NMDA receptor blockers Free radical inhibitors / scavengers - vitamin E, superoxide dismutase Ca channel blockers Nitric oxide synthetase inhibitors Erythropoitin Stem cell transplantation Hypothermia
41
Management - Hypothermia
Has become standard of care Whole-body and head-cooling available Unclear if one regimen is superior to the other - currently either one is utilized, based on availability Aim to get core (rectal) temperature to 33-35º C for 72 hours based on Cool Cap and NICHD Neonatal Research Network trials
42
Inclusion criteria for hypothermia
Gestational age>=36 week, wt >= 2000g Within 6 hrs of age Abnormal aEEG with minimum 20 min recording severely abnormal – upper margin<10 microV moderate- upper>10, lower < 5micro V Evidence of fetal and neonatal distress
43
Exclusion criteria Wt less than 2000gm,Gestation less than 36 wks
After 6 hrs,aEEG< 5micro V Lethal chromosomal anomaly – trisomy 13,18 Severe congenital anomaly Symptomatic systemic congenital viral infection Bleeding diathesis Major intracranial hemorrhage
44
Hypothermia - Mechanism of Action
Reduces cerebral metabolism, prevents edema Decreases energy utilization Reduces/suppresses cytotoxic amino acid accumulation and nitric oxide Inhibits platelet-activating factor, inflammatory cascade Suppresses free radical activity Attenuates secondary neuronal damage Inhibits cell death Reduces extent of brain damage DEATH OR SEVERE DISABILITY AT 18 MONTHS OF AGE SIGNIFICANTLY REDUCED!!
45
Hypothermia as a Treatment for HIE
Studies have shown that hypoxic ischemic injury can be reduced by brain cooling. Favorable effect on many of the pathways contributing to brain injury Excitatory amino acids Cerebral energy state Cerebral blood flow and metabolism Nitric oxide production Apoptosis
46
Selective Head Cooling
Whole Body Hypothermia
47
OUTCOME Stage I 0% 0% Stage II 5% 21% Stage III 75% 100%
Death CNS sequelae Stage I 0% % Stage II % % Stage III 75% % Outcome generally good in those who do not reach stage III and spend < 5/7 in stage II
48
DIFFERENTIAL DIAGNOSIS
Drug depression - maternal drugs, GA Prematurity Trauma - tentorial tear Anaemia Neuromuscular disorder Infection Inborn error of metabolism - Pyridoxine Dependency Respiratory tract malformation
49
Prognosis based on Apgar score
Score at 1, 5 minutes does not give prognosis indicator The longer the score remains lower, the greater its significance 0-3 at 1min has mortality of 5-10% may be increased to 53% if at 20min apgar score 0-3 0-3 at 5min , CP risk app. 1% may be increased to 9% if APS is 0-3 for 15min dramatic rise to 57% CP risk if APS is 0-3 for 20min
50
Predictors of poor neuro-developmental outcome
Failure to establish resp. by 5 minutes Apgar score of 3 or less at 5 minutes Onset of seizures with in 12 hours Refractory seizures Inability to establish oral feeds by 1 wk Abnormal EEG, neuro-imaging
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.